Review



mouse insulin like growth factor protein 4  (Cusabio)


Bioz Verified Symbol Cusabio is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    Cusabio mouse insulin like growth factor protein 4
    Mouse Insulin Like Growth Factor Protein 4, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+insulin+like+growth+factor+protein+4/Mouse+Insulin-like+growth+factor+binding+protein+4%2CIGFBP-4+ELISA+kit/pmc12348007-214-27-36
    Average 93 stars, based on 1 article reviews
    mouse insulin like growth factor protein 4 - by Bioz Stars, 2026-10
    93/100 stars

    Images

    Related Articles

    Enzyme-linked Immunosorbent Assay:

    Article Title: Elevated IGFBP4 and Cognitive Impairment in a PTFE-Induced Mouse Model of Obstructive Sleep Apnea
    Article Snippet: .. IGFBPs levels (i.e., IGFBP1 and IGFBP3) were quantified by the Magnetic Luminex Assay kit (R&D Systems Europe, Ltd., Abingdon, UK), and IGFBP4 levels were determined with the mouse insulin-like growth factor protein 4, IGFBP-4 ELISA kit (CUSABIO, code CSB-E07355m, CUBIO innovation center, Houston, TX, USA), following the manufacturer’s protocol. ..



    Similar Products

    mouse igfbp4  (ABclonal Biotechnology)
    93
    ABclonal Biotechnology mouse igfbp4
    Apo-hIGFBP4 complex with AAC2 exhibits distinct IR spectral and electrophoretic characteristics. ( a ) ATR FT-MIR spectra of hIGFBP4 with and without bound AAC2 were analyzed by spectral deconvolution in the 1600–1700 cm⁻¹ region. Highlighted are β-sheets, and α-helices. Each sample was measured five or more times and shown as representative samples. Statistical analysis was performed using one-way ANOVA. ( b ) ATR FT-MIR spectra of AAC2 with native and denatured by heat inactivation hIGFBP4 analyzed by spectral deconvolution in the 1600–1700 cm⁻¹ region. ( c ) Electrophoresis of hIGFBP4 (lane 1), AAC2 with denatured hIGFBP4 (lane 2), and AAC2 with native hIGFBP4 (lane 3), performed under native conditions. ( d ) AFM image of AAC2 and the <t>AAC2-IGFBP4</t> complex, with the enlarged regions shown in inserts d.1 and d.2. ( e , f ) Fiber diameter measurements (e, indicated by red circles) and corresponding histogram distribution ( f ) derived from AFM images of AAC2 ( n = 7) and the AAC2-IGFBP4 complex ( n = 9, * P = 0.03)
    Mouse Igfbp4, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+insulin+like+growth+factor+protein+4/Mouse+Insulin+Like+Growth+Factor+Binding+Protein+4+ELISA+Kit/pmc12853802-307-8-11
    Average 93 stars, based on 1 article reviews
    mouse igfbp4 - by Bioz Stars, 2026-10
    93/100 stars
    		  Buy from Supplier
    mouse insulin like growth factor protein 4  (Cusabio)
    93
    Cusabio mouse insulin like growth factor protein 4
    Apo-hIGFBP4 complex with AAC2 exhibits distinct IR spectral and electrophoretic characteristics. ( a ) ATR FT-MIR spectra of hIGFBP4 with and without bound AAC2 were analyzed by spectral deconvolution in the 1600–1700 cm⁻¹ region. Highlighted are β-sheets, and α-helices. Each sample was measured five or more times and shown as representative samples. Statistical analysis was performed using one-way ANOVA. ( b ) ATR FT-MIR spectra of AAC2 with native and denatured by heat inactivation hIGFBP4 analyzed by spectral deconvolution in the 1600–1700 cm⁻¹ region. ( c ) Electrophoresis of hIGFBP4 (lane 1), AAC2 with denatured hIGFBP4 (lane 2), and AAC2 with native hIGFBP4 (lane 3), performed under native conditions. ( d ) AFM image of AAC2 and the <t>AAC2-IGFBP4</t> complex, with the enlarged regions shown in inserts d.1 and d.2. ( e , f ) Fiber diameter measurements (e, indicated by red circles) and corresponding histogram distribution ( f ) derived from AFM images of AAC2 ( n = 7) and the AAC2-IGFBP4 complex ( n = 9, * P = 0.03)
    Mouse Insulin Like Growth Factor Protein 4, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+insulin+like+growth+factor+protein+4/Mouse+Insulin-like+growth+factor+binding+protein+4%2CIGFBP-4+ELISA+kit/pmc12348007-214-27-36
    Average 93 stars, based on 1 article reviews
    mouse insulin like growth factor protein 4 - by Bioz Stars, 2026-10
    93/100 stars
    		  Buy from Supplier
    igfbp 4 elisa kit  (Cusabio)
    93
    Cusabio igfbp 4 elisa kit
    Apo-hIGFBP4 complex with AAC2 exhibits distinct IR spectral and electrophoretic characteristics. ( a ) ATR FT-MIR spectra of hIGFBP4 with and without bound AAC2 were analyzed by spectral deconvolution in the 1600–1700 cm⁻¹ region. Highlighted are β-sheets, and α-helices. Each sample was measured five or more times and shown as representative samples. Statistical analysis was performed using one-way ANOVA. ( b ) ATR FT-MIR spectra of AAC2 with native and denatured by heat inactivation hIGFBP4 analyzed by spectral deconvolution in the 1600–1700 cm⁻¹ region. ( c ) Electrophoresis of hIGFBP4 (lane 1), AAC2 with denatured hIGFBP4 (lane 2), and AAC2 with native hIGFBP4 (lane 3), performed under native conditions. ( d ) AFM image of AAC2 and the <t>AAC2-IGFBP4</t> complex, with the enlarged regions shown in inserts d.1 and d.2. ( e , f ) Fiber diameter measurements (e, indicated by red circles) and corresponding histogram distribution ( f ) derived from AFM images of AAC2 ( n = 7) and the AAC2-IGFBP4 complex ( n = 9, * P = 0.03)
    Igfbp 4 Elisa Kit, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+insulin+like+growth+factor+protein+4/Mouse+Insulin-like+growth+factor+binding+protein+4%2CIGFBP-4+ELISA+kit/pmc12348007-214-33-36
    Average 93 stars, based on 1 article reviews
    igfbp 4 elisa kit - by Bioz Stars, 2026-10
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    Apo-hIGFBP4 complex with AAC2 exhibits distinct IR spectral and electrophoretic characteristics. ( a ) ATR FT-MIR spectra of hIGFBP4 with and without bound AAC2 were analyzed by spectral deconvolution in the 1600–1700 cm⁻¹ region. Highlighted are β-sheets, and α-helices. Each sample was measured five or more times and shown as representative samples. Statistical analysis was performed using one-way ANOVA. ( b ) ATR FT-MIR spectra of AAC2 with native and denatured by heat inactivation hIGFBP4 analyzed by spectral deconvolution in the 1600–1700 cm⁻¹ region. ( c ) Electrophoresis of hIGFBP4 (lane 1), AAC2 with denatured hIGFBP4 (lane 2), and AAC2 with native hIGFBP4 (lane 3), performed under native conditions. ( d ) AFM image of AAC2 and the AAC2-IGFBP4 complex, with the enlarged regions shown in inserts d.1 and d.2. ( e , f ) Fiber diameter measurements (e, indicated by red circles) and corresponding histogram distribution ( f ) derived from AFM images of AAC2 ( n = 7) and the AAC2-IGFBP4 complex ( n = 9, * P = 0.03)

    Journal: Journal of Nanobiotechnology

    Article Title: Bidirectional regulation of liver sinusoidal clearance by amino acid nanofibers and IGFBP4 complex: effects on HbA1c

    doi: 10.1186/s12951-025-03943-5

    Figure Lengend Snippet: Apo-hIGFBP4 complex with AAC2 exhibits distinct IR spectral and electrophoretic characteristics. ( a ) ATR FT-MIR spectra of hIGFBP4 with and without bound AAC2 were analyzed by spectral deconvolution in the 1600–1700 cm⁻¹ region. Highlighted are β-sheets, and α-helices. Each sample was measured five or more times and shown as representative samples. Statistical analysis was performed using one-way ANOVA. ( b ) ATR FT-MIR spectra of AAC2 with native and denatured by heat inactivation hIGFBP4 analyzed by spectral deconvolution in the 1600–1700 cm⁻¹ region. ( c ) Electrophoresis of hIGFBP4 (lane 1), AAC2 with denatured hIGFBP4 (lane 2), and AAC2 with native hIGFBP4 (lane 3), performed under native conditions. ( d ) AFM image of AAC2 and the AAC2-IGFBP4 complex, with the enlarged regions shown in inserts d.1 and d.2. ( e , f ) Fiber diameter measurements (e, indicated by red circles) and corresponding histogram distribution ( f ) derived from AFM images of AAC2 ( n = 7) and the AAC2-IGFBP4 complex ( n = 9, * P = 0.03)

    Article Snippet: Plasma concentrations of human IGFBP4 (hIGFBP4; ab100542, Abcam), mouse IGFBP4 (RK02921, Abclonal), and mouse IGF1 (ab100695, Abcam) were measured by ELISA 30 days after the initiation of treatment.

    Techniques: Electrophoresis, Derivative Assay

    AAC2-hIGFBP4 complex increased the circulation time of hIGFBP4 without influencing mouse IGFBP4 and IGF-1 levels. ( a ) schematic of the experiment showing four ob/ob male mouse groups ( n = 5 per group) treated with control (veh, PBS), AAC2 (0.1 nmol/g body weight, BW), hIGFBP4 (1.79 nmol/g BW), or AAC2-hIGFBP4 (0.1 nmol/g and 1.79 nmol/g, respectively) every 48 h for 30 days. All data are shown and mean ± SEM. (b–d) plasma levels of therapeutic hIGFBP4 ( b ), endogenous mouse IGFBP4 ( c ), and IGF-1 ( d ) measured by ELISA 30 days after the start of treatment. n.s., not significant by unpaired Student’s t-test. therapeutic hIGFBP4 ( b ), endogenous mouse IGFBP4 ( c ), and IGF-1 ( d ) measured by ELISA 30 days after the start of treatment. n.s., not significant by unpaired Student’s t-test

    Journal: Journal of Nanobiotechnology

    Article Title: Bidirectional regulation of liver sinusoidal clearance by amino acid nanofibers and IGFBP4 complex: effects on HbA1c

    doi: 10.1186/s12951-025-03943-5

    Figure Lengend Snippet: AAC2-hIGFBP4 complex increased the circulation time of hIGFBP4 without influencing mouse IGFBP4 and IGF-1 levels. ( a ) schematic of the experiment showing four ob/ob male mouse groups ( n = 5 per group) treated with control (veh, PBS), AAC2 (0.1 nmol/g body weight, BW), hIGFBP4 (1.79 nmol/g BW), or AAC2-hIGFBP4 (0.1 nmol/g and 1.79 nmol/g, respectively) every 48 h for 30 days. All data are shown and mean ± SEM. (b–d) plasma levels of therapeutic hIGFBP4 ( b ), endogenous mouse IGFBP4 ( c ), and IGF-1 ( d ) measured by ELISA 30 days after the start of treatment. n.s., not significant by unpaired Student’s t-test. therapeutic hIGFBP4 ( b ), endogenous mouse IGFBP4 ( c ), and IGF-1 ( d ) measured by ELISA 30 days after the start of treatment. n.s., not significant by unpaired Student’s t-test

    Article Snippet: Plasma concentrations of human IGFBP4 (hIGFBP4; ab100542, Abcam), mouse IGFBP4 (RK02921, Abclonal), and mouse IGF1 (ab100695, Abcam) were measured by ELISA 30 days after the initiation of treatment.

    Techniques: Control, Clinical Proteomics, Enzyme-linked Immunosorbent Assay